Lakefront Biotherapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
argenx SE USD 0 0 Mar/2025
AstraZeneca USD 1.18 0.56 Mar/2026
Genmab 0 0 Mar/2025
Gilead Sciences 2.29 0.29 Mar/2026
GlaxoSmithKline 0.82 3.75 Mar/2026
GRIFOLS 2.21 0.29 Mar/2026
Hikma Pharmaceutical USD 4.02 1.1 Dec/2025
Merck 2.04 0.25 Mar/2026
Novartis USD 3.33 0.29 Mar/2026
Roche Holding 2.96 0.8 Dec/2025
Sanofi 4.98 0.24 Mar/2026
UCB 0.58 0.25 Dec/2025